| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |